Exploring the Therapeutic Potential of Leea Indica Leaf Extract in Diabetic Mice: In Vivo, Phytochemical Analysis, and Molecular Interaction Studies
DOI:
https://doi.org/10.48048/tis.2025.10130Keywords:
Leea indica, Phytochemical profile, Molecular docking, Insulin deficiency, Insulin sensitivityAbstract
Diabetes mellitus remains a global health challenge, with limited effective treatments that address its root causes, including insulin resistance and insulin deficiency. The increasing prevalence of diabetes has required the exploration of alternative treatments, particularly from natural sources. Leea indica, a plant known for its medicinal properties, has gained attention for its potential antidiabetic effects. However, there is limited research exploring its therapeutic potential through comprehensive in vivo, phytochemical, and molecular docking studies. This study aimed to evaluate the antidiabetic effects of Leea indica leaf extract in a model of diabetic mice and explore its molecular mechanisms through docking studies. In vivo, results demonstrated that Leea indica extract significantly reduced insulin resistance and improved blood glucose regulation in a dose-dependent manner, with the 100 mg dose being particularly effective in lowering glucose levels to near-normal ranges. Histopathological analysis showed that the extract offered protective effects on pancreatic tissue, especially at moderate doses. Furthermore, molecular docking studies revealed that Leea indica ligands, NL and S18, exhibited stronger binding affinities for PPAR alpha compared to Acarbose, with the ligand S18 showing a particularly favorable ΔG of −10.6 kcal/mol and Ki of 0.01703 μM. These findings highlight the therapeutic potential of Leea indica leaf extract as a promising agent for the treatment of diabetes, with its phytochemicals showing favorable interactions at the molecular level. More research is needed to optimize the dose and understand the mechanisms of action that underlie its antidiabetic effects.
HIGHLIGHTS
- The study found that Leea indica leaf extract significantly reduced insulin resistance and helped regulate blood glucose levels in diabetic mice. The 100 mg dose was particularly effective, showing promising potential for managing diabetes.
- Histopathological analysis revealed that Leea indica leaf extract provided protective effects on pancreatic tissue, especially at moderate doses. This suggests that the extract could help maintain pancreatic health in diabetic conditions.
- Molecular docking studies identified two specific phytochemicals, NL and S18, within the extract, which showed stronger binding affinities for PPAR alpha receptors compared to Acarbose, a commonly used antidiabetic drug. This highlights the potential of these compounds as effective alternatives for diabetes treatment.
GRAPHICAL ABSTRACT
Downloads
References
CDC. Diabetic ketoacidosis. CDC, Bangkok, Thailand, 2021.
S Chatterjee, PK Khunti and PMJ Davies. Type 2 diabetes. The Lancet 2017; 389(10085), 2239-2251.
IH Kuan, RL Savage, SB Duffull, RJ Walker and DF Wright. The association between metformin therapy and lactic acidosis. Drug Safety 2019; 42, 1449-1469.
W Aligita, S Muhsinin, E Susilawati, D Pratiwi, D Aprilliani, A Artarini and I Adnyana. Antidiabetic activity of okra (Abelmoschus esculentus L.) fruit extract. RASAYAN Journal of Chemistry 2019; 12(1), 157-167.
Nursamsiar, Marwati, Khairuddin, FJ Sami, H Kasmawati, W Aligita, E Febrina and A Asnawi. Isolation, characterization, and in vitro inhibitory activity of a new alpha-glucosidase inhibitor from Schleichera oleosa (Lour.) Oken leaves. Journal of Pharmacy & Pharmacognosy Research 2025; 13(1), 140-151.
ASV Wyk and G Prinsloo. Health, safety and quality concerns of plant-based traditional medicines and herbal remedies. South African Journal of Botany 2020; 133, 54-62.
F Hossain, MG Mostofa and AK Alam. Traditional uses and pharmacological activities of the genus leea and its phytochemicals: A review. Heliyon 2021; 7, e06222.
NI Ischak, LO Aman, H Hasan, AL Kilo and A Asnawi. In silico screening of Andrographis paniculata secondary metabolites as anti-diabetes mellitus through PDE9 inhibition. Research in Pharmaceutical Sciences 2023; 18(1), 100-111.
YT Wondmkun. Obesity, insulin resistance, and type 2 diabetes: Associations and therapeutic implications. Diabetes, Metabolic Syndrome and Obesity 2020; 13, 3611-3616.
MS Rahman, KS Hossain, S Das, S Kundu, EO Adegoke, MA Rahman, MA Hannan, MJ Uddin and P Myung-Geol. Role of insulin in health and disease: An update. International Journal of Molecular Sciences 2021; 22(12), 6403.
M Prentki, P Marie-Line, P Masiello and SRM Madiraju. Nutrient-Induced metabolic stress, adaptation, detoxification, and toxicity in the pancreatic β-Cell. Diabetes 2020; 69(3), 279-290.
NKZ Zolkeflee, PL Wong, M Maulidiani, NS Ramli, A Azlan and Fh Abas. Metabolic alterations in Streptozotocin–nicotinamide-induced diabetic rats treated with muntingia calabura extract via 1H-NMR-based metabolomics. Planta Medica 2023; 89(9), 916-934.
PA Gerber and GA Rutter. The role of oxidative stress and hypoxia in pancreatic Beta-Cell dysfunction in diabetes mellitus. Antioxidants & Redox Signaling 2017; 26(10), 501-518.
DL Eizirik, L Pasquali and M Cnop. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: Different pathways to failure. Nature Reviews Endocrinology 2020; 16(7), 349-362.
AKA Gunawan, PS Yustiantara, PMNA Sari, DK Wati, MY Putra and IMAG Wirasuta. In silico and multivariate analysis of herbal compounds in asthma inflammation: Exploring alternatives to corticosteroids. Tropical Journal of Natural Product Research 2025; 9(2), 817-825.
E Febrina and A Asnawi. Lead compound discovery using pharmacophore-based models of small-molecule metabolites from human blood as inhibitor cellular entry of SARS-CoV-2. Journal of Pharmacy & Pharmacognosy Research 2023; 11(5), 810-822.
Y Li, N Ks, G Byran and PT Krishnamurthy. Identification of selective PPAR-γ modulators by combining pharmacophore modeling, molecular docking, and adipogenesis assay. Applied Biochemistry and Biotechnology 2023; 195(2), 1014-1041.
L Kousalya, P Seethapathy, D Pandita, S Packiaraj, S Venkatesh, S Sankaralingam, M Arunkumar, B Harinathan, A Pandita, R Casini, EA Mahmoud, IM Moussa and HO Elansary. Chitosan (CTS) induced secondary metabolite production in Canscora decussata Schult. - An endangered medicinal plant. Kuwait Journal of Science 2025; 52(1), 100306.
OE Ayegbusi, OT Aladesanmi, OE Kosemani and OA Adewusi. Effects of lead chloride on growth performance of clarias gariepinus (Burchell, 1822). International Journal of Bioassays 2018; 7(5), 5638-5644.
LO Aman, NI Ischak, TS Tuloli, A Arfan and A Asnawi. Multiple ligands simultaneous molecular docking and dynamics approach to study the synergetic inhibitory of curcumin analogs on ErbB4 tyrosine phosphorylation. Research in Pharmaceutical Sciences 2024; 19(6), 754-765.
A Asnawi, E Febrina, W Aligita, LO Aman and F Razi. Molecular docking and molecular dynamics study of 3-hydroxybutyrate with polymers for diabetic ketoacidosis-targeted molecularly imprinted polymers. Journal of Pharmacy & Pharmacognosy Research 2024; 12(5), 822-836.
HD Snyder and TG Kucukkal. Computational chemistry activities with Avogadro and ORCA. Journal of Chemical Education 2021; 98(4), 1335-1341.
GM Morris, R Huey, W Lindstrom, MF Sanner, RK Belew, DS Goodsell and AJ Olson. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry 2009; 30(16), 2785-2791.
A Asnawi, S Mieldianisa, W Aligita, A Yuliantini and E Febrina. Integrative computational approaches for designing novel alpha-glucosidase inhibitors based on curculigoside A derivatives: Virtual screening, molecular docking, and molecular dynamics. Journal of Herbmed Pharmacology 2024; 13(2), 308-323.
A Bernardi, R Faller, D Reith and KN Kirschner. ACPYPE update for nonuniform 1–4 scale factors: Conversion of the GLYCAM06 force field from AMBER to GROMACS. SoftwareX 2019; 10, 100241.
I Muhammad, N Rahman, U Nishan and M Shah. Antidiabetic activities of alkaloids isolated from medicinal plants. Brazilian Journal of Pharmaceutical Sciences 2021; 57, e19130.
Nursamsiar, S Nur, E Febrina, A Asnawi and S Syafiie. Synthesis and Inhibitory Activity of Curculigoside A Derivatives as Potential Anti-Diabetic Agents with β-Cell Apoptosis. Journal of Molecular Structure 2022; 1265,133292
SP Manavi, T Amiri and MJ Mozafaryan. Role of flavonoids in diabetes. Journal of Reviews in Medical Sciences 2021; 1(3), 149-161.
MAD Junior, RWN Edzang, AL Catto and JM Raimundo. Quinones as an efficient molecular scaffold in the antibacterial/antifungal or antitumoral arsenal. International Journal of Molecular Sciences 2022; 23(22), 14108.
N Choudhary, GL Khatik and A Suttee. The possible role of saponin in type-II diabetes-a review. Current diabetes reviews 2021; 17(2), 107-121.
D Kurnia, D Meilinawati, L Marliani, E Febrina and A Asnawi. A review of tannin compounds in avocado as antioxidants. Tropical Journal of Natural Product Research 2024; 8(10), 8607-8616.
Z Tong, W He, X Fan and A Guo. Biological function of plant tannin and its application in animal health. Frontiers in Veterinary Science 2022; 8, 803657.
Shivam, AK Gupta and S Kumar. Review on diabetic complications and their management by flavonoids and triterpenoids. The Natural Products Journal 2023; 13(8), 105-114.
SH Lee, SY Park and CS Choi. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes & Metabolism Journal 2022; 46(1), 15-37.
Z Zeng, L Liang, Z Feng, P Guo, X Hao, J Xian, H Feng, Y Chen and Z Chen. Glibenclamide pretreatment attenuates early hematoma expansion of warfarin-associated intracerebral hemorrhage in rats by alleviating perihematomal blood–brain barrier dysfunction. Chinese Neurosurgical Journal 2024; 10(01), 8-19.
J Zhang, X Wang, Y Lv, J Hou, C Zhang, X Su and L Li. Impact of stress hyperglycemia on long-term prognosis in acute pancreatitis without diabetes. Internal and Emergency Medicine 2024; 19(3), 681-688.
B Pucelik, A Barzowska and A Czarna. DYRK1A inhibitors leucettines and TGF-β inhibitor additively stimulate insulin production in beta cells, organoids, and isolated mouse islets. Plos One 2023; 18(5), e0285208.
AME Sayed, SM Basam, EMBA El-Naggar, HS Marzouk and S El-Hawary. LC–MS/MS and GC–MS profiling as well as the antimicrobial effect of leaves of selected Yucca species introduced to Egypt. Scientific Reports 2020; 10(1), 17778.
P Cronet, JF Petersen, R Folmer, N Blomberg, K Sjoblom, U Karlsson, EL Lindstedt and K Bamberg. Structure of the PPARα and-γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 2001; 9(8), 699-706.
SR Hubbard. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. The EMBO Journal 1997; 16(18), 5572-5581.
A Asnawi, LO Aman, Nursamsiar, A Yuliantini and E Febrina. Molecular docking and molecular dynamic studies: screening phytochemicals of Acalypha indica against BRAF kinase receptors for potential use in melanocytic tumours. RASAYAN Journal of Chemistry 2022; 15(02), 1352-1361.
TK Karami, S Hailu, S Feng, R Graham and HJ Gukasyan. Eyes on Lipinski’s rule of five: A New “rule of thumb” for physicochemical design space of ophthalmic drugs. Journal of Ocular Pharmacology and Therapeutics 2022; 38(1), 43-55.
E Febrina, P Regina, Y Susilawati, FF Sofian and A Asnawi. In silico screening of Laminaria japonica ligands as potential inhibitors of DPP-4 for type 2 diabetes treatment. Tropical Journal of Natural Product Research 2025; 9(1), 157-167.
Published
Issue
Section
License
Copyright (c) 2025 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
